Chemoinformaics analysis of Nonacosanoic acid
| Molecular Weight | 438.781 | nRot | 27 |
| Heavy Atom Molecular Weight | 380.317 | nRig | 24 |
| Exact Molecular Weight | 438.444 | nRing | 0 |
| Solubility: LogS | -2.81 | nHRing | 0 |
| Solubility: LogP | 1.376 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 89 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 31 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 58 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 29 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 88.708 |
| nHD | 1 | BPOL | 59.054 |
| QED | 0.821 |
| Synth | 6.438 |
| Natural Product Likeliness | 2.407 |
| NR-PPAR-gamma | 0.002 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.472 |
| Pgp-sub | 0.667 |
| HIA | 0.364 |
| CACO-2 | -5.086 |
| MDCK | 0.0000349 |
| BBB | 0.232 |
| PPB | 0.0961997 |
| VDSS | 1.41 |
| FU | 0.778668 |
| CYP1A2-inh | 0.014 |
| CYP1A2-sub | 0.814 |
| CYP2c19-inh | 0.062 |
| CYP2c19-sub | 0.947 |
| CYP2c9-inh | 0.015 |
| CYP2c9-sub | 0.195 |
| CYP2d6-inh | 0.01 |
| CYP2d6-sub | 0.704 |
| CYP3a4-inh | 0.283 |
| CYP3a4-sub | 0.917 |
| CL | 7.078 |
| T12 | 0.051 |
| hERG | 0.718 |
| Ames | 0.812 |
| ROA | 0.625 |
| SkinSen | 0.125 |
| Carcinogencity | 0.763 |
| EI | 0.005 |
| Respiratory | 0.905 |
| NR-Aromatase | 0.927 |
| Antiviral | No |
| Prediction | 0.631678 |